HeartSciences (HSCS) CEO Andrew Simpson talks about the need to address the biggest killer of people in the United States through a low cost, simple to perform test such as the EKG. HeartSciences is applying advanced science and then machine learning or artificial intelligence (AI) to the EKG to make it a much more valuable […]
A heart attack is not a good way to find out you’ve got heart disease. Most people are surprised to learn – we know that heart disease is more deadly than *all* cancers combined. See full Twitter post with video presentation: (1) HeartSciences $HSCS on Twitter: “A heart attack is not a good way to […]
We’re working to change what’s possible with an ECG so that it can detect cardiac dysfunction at an early stage. This has been described as “one of the most significant advances in electrocardiography since its inception.” See full Twitter post with video presentation: (1) HeartSciences $HSCS on Twitter: “📺 TV Interview with $HSCS CEO Andrew […]
Southlake, Texas, Feb. 07, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced that Andrew Simpson, Chief Executive Officer […]
Israeli patent covers a country known as a hotbed for medical device innovation Southlake, Texas, Feb. 06, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the […]
Granted Korean Patent for its MyoVista® Wavelet Technology Southlake, Texas, Feb. 03, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), […]
To see the video, follow the link: https://proactiveinvestors.com/companies/news/1004693/heartsciences-using-technology-to-help-make-lifesaving-ecg-s-better-using-artificial-intelligence-1004693.html?viewSource=SkyAlphabet
Jan 20, 2023 Southlake, Texas, Jan. 20, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG), a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced that Andrew […]
Jan 4, 2023 Southlake, TX, Jan. 04, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced it has appointed […]
Dec 16, 2022 Patient Enrollment Close to Completion and Continue to Target FDA De Novo Resubmission Around Current Fiscal Year End Southlake, Texas, Dec. 16, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) […]
©2023. ™ Trademark of HeartSciences. Reg. US Pat. & TM off. All Rights Reserved.
MV-WBSTE-001 Rev B
wavECG and wavEKG are trademarks of HeartSciences.
